Enjoy complimentary customisation on priority with our Enterprise License!
The anti-thrombin III testing market share is expected to increase to USD 161.48 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.73%.
This anti-thrombin III testing market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers anti-thrombin III testing market segmentation by end-user (hospitals, laboratories, and academic and research institutes) and geography (North America, Europe, Asia, and Rest of World (ROW)). The anti-thrombin III testing market report also offers information on several market vendors, including Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biron Health Group Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Invitae Corp., Merck KGaA, Meridian Bioscience Inc., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Scripps Laboratories Inc., Sekisui Diagnostics LLC, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., and Werfenlife SA among others.
Download the Free Report Sample to Unlock the Anti-Thrombin III Testing Market Size for the Forecast Period and Other Important Statistics
The existence of tests related to anti-thrombin III is notably driving the anti-thrombin III testing market growth, although factors such as lack of clinically available protocols to treat anti-thrombin deficiency may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the anti-thrombin III testing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Anti-Thrombin III Testing Market Driver
One of the key factors driving the global anti-thrombin III testing market growth is the existence of tests for patients with anti-thrombin deficiency. The testing comprises a range of related tests, which aid in the detection of blood clots, as given below:
The presence of such tests, which aid in timely medical intervention and enable the correct treatment of patients, will boost the demand for anti-thrombin III testing products during the forecast period.
Key Anti-Thrombin III Testing Market Trend
The presence of various blood clotting disorders is one of the key anti-thrombin III testing market trends that is expected to impact the industry positively in the forecast period. Anti-thrombin presents many symptoms that are very similar to other disorders, such as protein S deficiency, antiphospholipid syndrome, and protein C deficiency.
Key Anti-Thrombin III Testing Market Challenge
One of the key challenges to the global anti-thrombin III testing market growth is the lack of clinically available protocols to treat anti-thrombin deficiency. Intravenous anti-thrombin concentrates are prescribed during surgery or child delivery, which are used to prevent venous clots when blood thinners such as heparin are not advisable, as they can lead to an increased risk of bleeding. For heparin to work effectively, an adequate amount of anti-thrombin must be present in the blood. Pregnant women with anti-thrombin deficiency are at a particularly high risk of developing clots during pregnancy or after delivery. In addition, patients with anti-thrombin deficiency who undergo surgery are at increased risk unless appropriate preventive measures are taken. Thus, the lack of clinically available protocols to treat anti-thrombin deficiency may hamper the demand for anti-thrombin kits and reagents and limit the market growth in the coming years.
This anti-thrombin III testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global anti-thrombin III testing market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the anti-thrombin III testing market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the anti-thrombin III testing market encompasses successful business strategies deployed by the key vendors. The anti-thrombin III testing market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.
To make the most of the opportunities and recover from post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The anti-thrombin III testing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the anti-thrombin III testing market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for anti-thrombin III testing in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The growing adoption of anti-thrombin III testing for blood disorders in hospitals and laboratories will facilitate the anti-thrombin III testing market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The cases of COVID-19 have increased significantly across North America. For instance, according to the Centers for Medicare and Medicaid Services (CMS), healthcare expenditure in the US was around USD 12,530 per person in 2021, an increase of 4.6% from the previous year. The growing prevalence of COVID-19 has increased the demand for a wide range of anti-thrombin III testing for the treatment of patients with COVID-19. Furthermore, governments' desire to provide the greatest health care fuels the demand for innovative treatments. This feature is projected to create a favorable environment for the regional anti-thrombin III testing market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The anti-thrombin III testing market share growth by the hospital segment will be significant during the forecast period. Hospitals make use of anti-thrombin III testing products like assay kits, reagents, and systems to carry out diagnostic tests. The sales of anti-thrombin III testing products in hospitals will increase due to the increase in patient admissions for surgeries and diagnoses.
This report provides an accurate prediction of the contribution of all the segments to the growth of the anti-thrombin III testing market size and actionable market insights on the post-COVID-19 impact on each segment.
Anti-Thrombin III Testing Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.73% |
Market growth 2022-2026 |
$161.48 million |
Market structure |
Fragmented |
YoY growth (%) |
5.3 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biron Health Group Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Invitae Corp., Merck KGaA, Meridian Bioscience Inc., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Scripps Laboratories Inc., Sekisui Diagnostics LLC, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., and Werfenlife SA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.